8-19961566-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000237.3(LPL):c.1322+483T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.282 in 152,060 control chromosomes in the GnomAD database, including 6,080 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.28 ( 6080 hom., cov: 31)
Consequence
LPL
NM_000237.3 intron
NM_000237.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.172
Publications
89 publications found
Genes affected
LPL (HGNC:6677): (lipoprotein lipase) LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq, Jul 2008]
LPL Gene-Disease associations (from GenCC):
- familial lipoprotein lipase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hyperlipidemia, familial combined, LPL relatedInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 8-19961566-T-G is Benign according to our data. Variant chr8-19961566-T-G is described in ClinVar as Benign. ClinVar VariationId is 1165812.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.312 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LPL | NM_000237.3 | c.1322+483T>G | intron_variant | Intron 8 of 9 | ENST00000650287.1 | NP_000228.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LPL | ENST00000650287.1 | c.1322+483T>G | intron_variant | Intron 8 of 9 | NM_000237.3 | ENSP00000497642.1 | ||||
| LPL | ENST00000650478.1 | n.*145+483T>G | intron_variant | Intron 2 of 3 | ENSP00000497560.1 |
Frequencies
GnomAD3 genomes AF: 0.282 AC: 42808AN: 151942Hom.: 6073 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
42808
AN:
151942
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.282 AC: 42827AN: 152060Hom.: 6080 Cov.: 31 AF XY: 0.278 AC XY: 20682AN XY: 74340 show subpopulations
GnomAD4 genome
AF:
AC:
42827
AN:
152060
Hom.:
Cov.:
31
AF XY:
AC XY:
20682
AN XY:
74340
show subpopulations
African (AFR)
AF:
AC:
13125
AN:
41428
American (AMR)
AF:
AC:
3960
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1311
AN:
3470
East Asian (EAS)
AF:
AC:
1073
AN:
5178
South Asian (SAS)
AF:
AC:
1083
AN:
4816
European-Finnish (FIN)
AF:
AC:
2648
AN:
10578
Middle Eastern (MID)
AF:
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
AC:
18617
AN:
67986
Other (OTH)
AF:
AC:
575
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1590
3180
4769
6359
7949
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
428
856
1284
1712
2140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Nov 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.